Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Razieh Kebriaei

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Antibiotics (Basel, Switzerland)|November 11, 2022
Editorial: <i>Antibiotics</i> Special Issue on Pharmacokinetic/Pharmacodynamic Models of AntibioticsRazieh Kebriaei, Andrew D Berti
Pharmacotherapy|May 24, 2020
Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19Sarah C J Jorgensen, Razieh Kebriaei, Linda D Dresser
Antimicrobial Agents and Chemotherapy|January 24, 2019
Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of <i>Staphylococcus aureus</i> in a Simulated Pharmacodynamic/Pharmacokinetic ModelRazieh Kebriaei, Seth A Rice, Kyle C Stamper, et al.
Antibiotics (Basel, Switzerland)|June 2, 2021
Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant <i>Pseudomonas aeruginosa</i> InfectionsDana Holger, Razieh Kebriaei, Taylor Morrisette, et al.
Pharmacotherapy|December 25, 2019
Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic CombinationsTaylor Morrisette, Razieh Kebriaei, Katherine L Lev, et al.
Infectious Diseases and Therapy|March 10, 2019
Teaching an Old Class New Tricks: A Novel Semi-Synthetic Aminoglycoside, PlazomicinJacinda C Abdul-Mutakabbir, Razieh Kebriaei, Sarah C J Jorgensen, et al.
Plos Biology|May 23, 2023
Translating phage therapy into the clinic: Recent accomplishments but continuing challengesAleksandra Petrovic Fabijan, Jonathan Iredell, Katarzyna Danis-Wlodarczyk, et al.
Antibiotics (Basel, Switzerland)|November 4, 2020
The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA-Salvaging the Gold Standards with Combination TherapyTaylor Morrisette, Sara Alosaimy, Jacinda C Abdul-Mutakabbir, et al.
Pharmacotherapy|October 17, 2020
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug-Resistant Gram-Negative PathogensJacinda C Abdul-Mutakabbir, Sara Alosaimy, Taylor Morrisette, et al.
Antibiotics (Basel, Switzerland)|August 27, 2021
Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant <i>Enterococcus</i> <i>faecium</i> and <i>faecalis</i>Katie E Barber, Zade Shammout, Jordan R Smith, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Antibiotics (Basel, Switzerland)|November 11, 2022
Editorial: <i>Antibiotics</i> Special Issue on Pharmacokinetic/Pharmacodynamic Models of AntibioticsRazieh Kebriaei, Andrew D Berti
Pharmacotherapy|May 24, 2020
Remdesivir: Review of Pharmacology, Pre-clinical Data, and Emerging Clinical Experience for COVID-19Sarah C J Jorgensen, Razieh Kebriaei, Linda D Dresser
Antimicrobial Agents and Chemotherapy|January 24, 2019
Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of <i>Staphylococcus aureus</i> in a Simulated Pharmacodynamic/Pharmacokinetic ModelRazieh Kebriaei, Seth A Rice, Kyle C Stamper, et al.
Antibiotics (Basel, Switzerland)|June 2, 2021
Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant <i>Pseudomonas aeruginosa</i> InfectionsDana Holger, Razieh Kebriaei, Taylor Morrisette, et al.
Pharmacotherapy|December 25, 2019
Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic CombinationsTaylor Morrisette, Razieh Kebriaei, Katherine L Lev, et al.
Infectious Diseases and Therapy|March 10, 2019
Teaching an Old Class New Tricks: A Novel Semi-Synthetic Aminoglycoside, PlazomicinJacinda C Abdul-Mutakabbir, Razieh Kebriaei, Sarah C J Jorgensen, et al.
Plos Biology|May 23, 2023
Translating phage therapy into the clinic: Recent accomplishments but continuing challengesAleksandra Petrovic Fabijan, Jonathan Iredell, Katarzyna Danis-Wlodarczyk, et al.
Antibiotics (Basel, Switzerland)|November 4, 2020
The Evolving Reduction of Vancomycin and Daptomycin Susceptibility in MRSA-Salvaging the Gold Standards with Combination TherapyTaylor Morrisette, Sara Alosaimy, Jacinda C Abdul-Mutakabbir, et al.
Pharmacotherapy|October 17, 2020
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug-Resistant Gram-Negative PathogensJacinda C Abdul-Mutakabbir, Sara Alosaimy, Taylor Morrisette, et al.
Antibiotics (Basel, Switzerland)|August 27, 2021
Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant <i>Enterococcus</i> <i>faecium</i> and <i>faecalis</i>Katie E Barber, Zade Shammout, Jordan R Smith, et al.
Pageof 5